Vaccines 
and Biologics for Global Health Crises

The SPEEDCELL project is a four-year EU-funded initiative led by HIPRA

To accelerate the development and production of biologics, enabling a swift response to health emergencies, aligned with the EU’s “100 Days Mission”.

Year project
0
EUR Funding
0 M
Time reduction goal in production
%
Days goal
0

Accelerate the development and production of biologics

The project aligns with European strategies to strengthen health security and address systemic medicine shortages, particularly in the context of health crises and pandemics.

CHALLENGES

Reducing the
time-to-market

For new vaccines and therapeutic biologics in response to emerging health threats.

Manufacturing
infrastructure

Building a flexible, multi-technology manufacturing infrastructure capable of rapidly pivoting to new targets.

Production
scalability

Improving production scalability while maintaining product safety, efficacy, and quality.

Europe’s strategic
autonomy

Contributing to Europe’s strategic autonomy in the field of pandemic preparedness and biopharmaceutical production.

MISSION

SPEEDCELL’s mission is to boost Europe’s ability to respond to health emergencies by streamlining cell line development and manufacturing. 

News

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.